Doctors handing out screening kits could prevent colon cancer
NCT ID NCT06664567
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This trial tests whether having general practitioners (GPs) proactively give colorectal cancer screening kits to eligible patients (ages 50-74) increases screening rates compared to the usual practice of sending an invitation letter. Over 26,000 participants will be involved. The goal is to see if a simple change in how screening is offered can catch more cancers early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- colorectal cancer screening test
- What this could lead to
- If this works, it could show that a simple change in how doctors offer screening can catch more colorectal cancers early, potentially saving lives.
- What could go wrong
- This is a large trial, but it only measures participation rates, not actual cancer outcomes. The approach may not work in other regions or healthcare systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?